von Borstel & Associates’s Johnson & Johnson JNJ Stock Holding History

von Borstel & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,435	Closed	-$1.21M	–	101
2025 Q3	$1.21M	Buy	+6,435	New	+$1.1M	0.19%	62
2025 Q2	–	Sell	-301	Closed	-$49K	–	91
2025 Q1	$49K	Buy	+301	New	+$47.1K	0.01%	75

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

von Borstel & Associates's JNJ Position: Q4 2025 in Review

von Borstel & Associates sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 6,435 shares — an estimated $1.21M sold.

von Borstel & Associates first reported a position in JNJ in Q1 2025 and held it in 2 quarters. The position peaked at $1.21M in Q3 2025. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

von Borstel & Associates reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
von Borstel & Associates sold 6,435 Johnson & Johnson shares in Q4 2025, an estimated $1.21M.
von Borstel & Associates first reported a position in Johnson & Johnson in Q1 2025 and held it in 2 quarters.
von Borstel & Associates's Johnson & Johnson position peaked at $1.21M in Q3 2025.
4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on von Borstel & Associates's 13F filing for Q4 2025, filed 12 Feb 2026.